Melanoma in solid organ transplant recipients

Keyphrases

• Aggressive Course 50%
• Breslow Depth 100%
• Clinical Course 50%
• Clinical Evidence 50%
• Donor-transmitted 50%
• Early Detection 50%
• Immunosuppressed 50%
• Immunosuppression 50%
• In Situ Melanoma 50%
• Melanoma 100%
• Metastasis 100%
• Patient Education 50%
• Pretransplant 100%
• Prognostic Benefit 50%
• Recurrence Index 50%
• Regular Screening 50%
• Risk Analysis 50%
• Risk Estimation 50%
• Sentinel Lymph Node Biopsy 50%
• Solid Organ Transplant Recipients 100%
• Staging Criteria 50%
• Survival Estimation 50%
• Thin Melanoma 50%
• Transplant Population 100%
• Transplant Recipients 50%
• Transplant Team 50%
• Transplantation 50%
• Waiting Time 50%

Medicine and Dentistry

• Breslow's Depth 66%
• Clinical Study 33%
• Disease Course 33%
• Immunosuppressive Treatment 33%
• Melanoma 100%
• Metastatic Carcinoma 66%
• Recurrent Disease 33%
• Sentinel Lymph Node Biopsy 33%
• Survival Estimate 33%